Does Dr. SANJEEV BHAVNANI have financial conflicts of interest?

Dr. SANJEEV BHAVNANI (M.D.) has received a total of $13,955 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $13,955 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SANJEEV BHAVNANI?

According to CMS Open Payments data, Dr. SANJEEV BHAVNANI received funding from E.R. SQUIBB & SONS, L.L.C ($6,936), PFIZER ($6,662), and KINIKSA PHARMACEUTICALS ($68).

Does Dr. SANJEEV BHAVNANI receive research grants or speaking fees?

Dr. SANJEEV BHAVNANI has received $13,955 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SANJEEV BHAVNANI

M.D.Real-Time Hydrated

Specialty: Nuclear Medicine, Nuclear Cardiology

Practice Location: HARTFORD, CT 06102

NPI Number: 1578740098

LIFETIME INDUSTRY VALUE

$13,955

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BHAVNANI is a verified Nuclear Medicine, Nuclear Cardiology practitioner based in HARTFORD, CT.

Between 2021 and 2025, Dr. BHAVNANI had an overall industry promotional and research financial footprint of $13,955 as recorded in the federal CMS Open Payments database.

$13,955 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BHAVNANI's primary funding source is E.R. SQUIBB & SONS, L.L.C, which accounts for $6,936 (representing 49.7% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

E.R. SQUIBB & SONS, L.L.C

Rank 1

$6,936

49.7%

PFIZER

Rank 2

$6,662

47.7%

KINIKSA PHARMACEUTICALS

Rank 3

$68

0.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.